The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis
ConclusionsA higher 2 h-PCP/FCP ratio and a lack of previous insulin treatment increase the likelihood of BOT success.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: China Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Study